ETLI:F:F-Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 8.459

Change

-0.09 (-1.08)%

Market Cap

USD 0.02B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-18 )

ETFs Containing ETLI:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.74% 12% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.74% 11% F 29% F
Trailing 12 Months  
Capital Gain -19.76% 13% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.76% 12% F 30% F
Trailing 5 Years  
Capital Gain -0.15% 34% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.15% 34% F 34% F
Average Annual (5 Year Horizon)  
Capital Gain 3.19% 60% D- 61% D-
Dividend Return 3.19% 59% D- 56% F
Total Return N/A 25% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 12.73% 50% F 74% C
Risk Adjusted Return 25.04% 55% F 59% D-
Market Capitalization 0.02B 8% B- 17% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.